Patanjali Group Clocks Rs 30k Cr Turnover In FY21 Aims To Grow Higher
- ByAyushi Ray | July 14, 2021
Patanjali Group clocks Rs 30k Cr turnover in FY21. Patanjali Natural Biscuits reported a turnover of Rs 650 crore, Ayurveda arm Divya Pharmacy of Rs 850 crore and food processing arm Patanjali Agro of Rs 1,600 crore during the fiscal 2020-21, it added. Transportation wing Patanjali Parivahan reported a turnover of Rs 548 crore and Patanjali Gramoudyog Rs 396 crore during the fiscal. On the performance of the group’s newly acquired firm Ruchi Soya Industries, yoga guru Ramdev said, “In Ruchi Soya, we have grown about 24 percent and in Patanjali, we have grown from around Rs 11,000 crore (in FY20) to Rs 14,000 crore (in FY21). We have achieved a growth rate of 10 to 24 percent in our companies.” When asked about the impact on the business on account of disruptions to supply chains last fiscal, Ramdev said: “We have lesser impact as we have our transportation wing Patanjali Parivahan.”
The patanjali group is soon going to bring FPO of Ruchi Soya and is expecting to raise around Rs 4,300 crore. However, when asked about the dilution of Patanjali’s stake in Ruchi Soya, Ramdev declined to comment on this. “We have filed DRHP (with SEBI) and expect to get the nod soon,” he added. He also hinted towards the listing of Patanjali Ayurved very soon. “We will soon share some news about Patanjali. How much we have to demerge and when to list Patanjali Ayurved,” he said. On the group’s investment plans, Baba Ramdev said: “In the coming five years, our investment would be between Rs 5,000 crore and Rs 10,000 crore, ranging from our operations to agriculture and research.” According to Ramdev, Ruchi Soya has a debt of around Rs 3,300 crore. “The money which we are going to raise (from FPO), 40 percent of that would go for debt clearance and we aim to make this company (Ruchi Soya) debt-free,” he said adding “our target is to make a debt-free company… and provide 20 to 25 per cent return to our shareholders.” However, he did not share the debt figures of Patanjali Ayurved and other group companies.